FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020954005> ?p ?o ?g. }

• W2020954005 endingPage "103" @default.
• W2020954005 startingPage "98" @default.
• W2020954005 abstract "In an earlier study, we have observed an increase of alpha-tocopherol in breast cancer patients treated with third-generation aromatase inhibitors that was related to tamoxifen withdrawal. We report here the results of measurement of alpha-tocopherol in erythrocytes and alpha-tocopherol/cholesterol ratios in patients treated with letrozol. Alpha-tocopherol in lipoprotein fractions and erythrocytes was determined by high-performance liquid chromatography in 124 post-menopausal women with breast cancer treated with letrozol immediately before the start of treatment as well as 2 and 4 mo later. After a transient decrease after 2 mo of letrozol therapy, erythrocyte alpha-tocopherol concentrations returned to pre-treatment levels 4 mo after the start of treatment. Apart from lower cholesterol in patients pre-treated with tamoxifen, no significant differences were observed at baseline between patients previously treated with tamoxifen and patients who had no prior tamoxifen in any of the other parameters investigated, but the transient decrease of erythrocyte alpha-tocopherol was observed only in patients previously treated with tamoxifen. Alpha-tocopherol content of lipoprotein fractions was significantly increased 4 mo after the start of therapy, but this increase was evident mostly in patients not treated earlier with tamoxifen. In conclusion, only minor changes of alpha-tocopherol, including a transient decrease of alpha-tocopherol in erythrocyte membranes, and an increase of alpha-tocopherol in lipoprotein fractions were observed during the first 4 mo of letrozol therapy." @default.
• W2020954005 created "2016-06-24" @default.
• W2020954005 creator A5009523282 @default.
• W2020954005 creator A5012166679 @default.
• W2020954005 creator A5020329469 @default.
• W2020954005 creator A5038039431 @default.
• W2020954005 creator A5055122791 @default.
• W2020954005 creator A5064425904 @default.
• W2020954005 creator A5068334360 @default.
• W2020954005 creator A5089948892 @default.
• W2020954005 date "2010-01-01" @default.
• W2020954005 modified "2023-09-28" @default.
• W2020954005 title "Erythrocyte Alpha-Tocopherol in Breast Cancer Patients Treated with Letrozol" @default.
• W2020954005 cites W1157627380 @default.
• W2020954005 cites W125627109 @default.
• W2020954005 cites W1839333839 @default.
• W2020954005 cites W1918073772 @default.
• W2020954005 cites W1932574503 @default.
• W2020954005 cites W1989731044 @default.
• W2020954005 cites W2003179352 @default.
• W2020954005 cites W2020178214 @default.
• W2020954005 cites W2035064090 @default.
• W2020954005 cites W2042787106 @default.
• W2020954005 cites W2052278543 @default.
• W2020954005 cites W2055703143 @default.
• W2020954005 cites W2078385186 @default.
• W2020954005 cites W2090442653 @default.
• W2020954005 cites W2094127871 @default.
• W2020954005 cites W2101881391 @default.
• W2020954005 cites W2116749308 @default.
• W2020954005 cites W2121656289 @default.
• W2020954005 cites W2153288705 @default.
• W2020954005 cites W2154022201 @default.
• W2020954005 cites W2159127902 @default.
• W2020954005 cites W2181552651 @default.
• W2020954005 cites W2289939698 @default.
• W2020954005 cites W67516152 @default.
• W2020954005 doi "https://doi.org/10.3177/jnsv.56.98" @default.
• W2020954005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20495290" @default.
• W2020954005 hasPublicationYear "2010" @default.
• W2020954005 type Work @default.
• W2020954005 sameAs 2020954005 @default.
• W2020954005 citedByCount "2" @default.
• W2020954005 countsByYear W20209540052014 @default.
• W2020954005 countsByYear W20209540052015 @default.
• W2020954005 crossrefType "journal-article" @default.
• W2020954005 hasAuthorship W2020954005A5009523282 @default.
• W2020954005 hasAuthorship W2020954005A5012166679 @default.
• W2020954005 hasAuthorship W2020954005A5020329469 @default.
• W2020954005 hasAuthorship W2020954005A5038039431 @default.
• W2020954005 hasAuthorship W2020954005A5055122791 @default.
• W2020954005 hasAuthorship W2020954005A5064425904 @default.
• W2020954005 hasAuthorship W2020954005A5068334360 @default.
• W2020954005 hasAuthorship W2020954005A5089948892 @default.
• W2020954005 hasBestOaLocation W20209540051 @default.
• W2020954005 hasConcept C121608353 @default.
• W2020954005 hasConcept C126322002 @default.
• W2020954005 hasConcept C134018914 @default.
• W2020954005 hasConcept C141071460 @default.
• W2020954005 hasConcept C185592680 @default.
• W2020954005 hasConcept C2775944032 @default.
• W2020954005 hasConcept C2777176818 @default.
• W2020954005 hasConcept C2777551382 @default.
• W2020954005 hasConcept C2778004101 @default.
• W2020954005 hasConcept C2778163477 @default.
• W2020954005 hasConcept C2779924751 @default.
• W2020954005 hasConcept C2780072125 @default.
• W2020954005 hasConcept C2781449162 @default.
• W2020954005 hasConcept C49453240 @default.
• W2020954005 hasConcept C530470458 @default.
• W2020954005 hasConcept C55493867 @default.
• W2020954005 hasConcept C64943373 @default.
• W2020954005 hasConcept C71924100 @default.
• W2020954005 hasConcept C90924648 @default.
• W2020954005 hasConceptScore W2020954005C121608353 @default.
• W2020954005 hasConceptScore W2020954005C126322002 @default.
• W2020954005 hasConceptScore W2020954005C134018914 @default.
• W2020954005 hasConceptScore W2020954005C141071460 @default.
• W2020954005 hasConceptScore W2020954005C185592680 @default.
• W2020954005 hasConceptScore W2020954005C2775944032 @default.
• W2020954005 hasConceptScore W2020954005C2777176818 @default.
• W2020954005 hasConceptScore W2020954005C2777551382 @default.
• W2020954005 hasConceptScore W2020954005C2778004101 @default.
• W2020954005 hasConceptScore W2020954005C2778163477 @default.
• W2020954005 hasConceptScore W2020954005C2779924751 @default.
• W2020954005 hasConceptScore W2020954005C2780072125 @default.
• W2020954005 hasConceptScore W2020954005C2781449162 @default.
• W2020954005 hasConceptScore W2020954005C49453240 @default.
• W2020954005 hasConceptScore W2020954005C530470458 @default.
• W2020954005 hasConceptScore W2020954005C55493867 @default.
• W2020954005 hasConceptScore W2020954005C64943373 @default.
• W2020954005 hasConceptScore W2020954005C71924100 @default.
• W2020954005 hasConceptScore W2020954005C90924648 @default.
• W2020954005 hasIssue "2" @default.
• W2020954005 hasLocation W20209540051 @default.
• W2020954005 hasLocation W20209540052 @default.
• W2020954005 hasOpenAccess W2020954005 @default.
• W2020954005 hasPrimaryLocation W20209540051 @default.

• next